Have a feature idea you'd love to see implemented?
Let us know!
OMIC Singular Genomics Systems Inc
Price (delayed)
$21.9
Market cap
$55.01M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$34.79
Enterprise value
$52.28M
Highlights
Singular Genomics Systems's debt has decreased by 34% YoY and by 30% QoQ
OMIC's EPS is up by 10% year-on-year and by 7% since the previous quarter
OMIC's revenue is up by 2.7% year-on-year but it is down by 2.1% since the previous quarter
OMIC's quick ratio is down by 48% year-on-year and by 18% since the previous quarter
Singular Genomics Systems's equity has decreased by 38% YoY and by 10% QoQ
Key stats
What are the main financial stats of OMIC
Market
Valuations
Earnings
Shares outstanding
2.51M
Market cap
$55.01M
Enterprise value
$52.28M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.44
Price to sales (P/S)
20.55
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
19.61
Revenue
$2.67M
EBIT
-$85.18M
EBITDA
-$78.33M
Free cash flow
-$80.86M
Per share
Balance sheet
Liquidity
EPS
-$34.79
Free cash flow per share
-$32.33
Book value per share
$49.39
Revenue per share
$1.07
TBVPS
$74.59
Total assets
$186.55M
Total liabilities
$63.3M
Debt
$50.49M
Equity
$123.25M
Working capital
$112.2M
Debt to equity
0.41
Current ratio
7.37
Quick ratio
6.51
Net debt/EBITDA
0.03
Margins
Efficiency
Dividend
EBITDA margin
-2,938.2%
Gross margin
-50.8%
Net margin
-3,237.9%
Operating margin
-3,488.5%
Return on assets
-37.9%
Return on equity
-57.9%
Return on invested capital
-34.5%
Return on capital employed
-50.4%
Return on sales
-3,195%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
OMIC stock price
How has the Singular Genomics Systems stock price performed over time
Intraday
1.01%
1 week
-3.74%
1 month
45.03%
1 year
77.18%
YTD
58.7%
QTD
39.76%
Financial performance
How have Singular Genomics Systems's revenue and profit performed over time
Revenue
$2.67M
Gross profit
-$1.36M
Operating income
-$93M
Net income
-$86.32M
Gross margin
-50.8%
Net margin
-3,237.9%
OMIC's gross margin is down by 24% since the previous quarter
The gross profit has declined by 21% since the previous quarter
OMIC's operating margin is up by 10% year-on-year and by 4.5% since the previous quarter
Singular Genomics Systems's net margin has increased by 9% YoY and by 4.1% QoQ
Growth
What is Singular Genomics Systems's growth rate over time
Valuation
What is Singular Genomics Systems stock price valuation
P/E
N/A
P/B
0.44
P/S
20.55
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
19.61
OMIC's EPS is up by 10% year-on-year and by 7% since the previous quarter
The P/B is 120% above the last 4 quarters average of 0.2
Singular Genomics Systems's equity has decreased by 38% YoY and by 10% QoQ
OMIC's price to sales (P/S) is 67% more than its last 4 quarters average of 12.3
OMIC's revenue is up by 2.7% year-on-year but it is down by 2.1% since the previous quarter
Efficiency
How efficient is Singular Genomics Systems business performance
The ROE has contracted by 43% YoY and by 6% from the previous quarter
The ROA has contracted by 23% YoY and by 4.1% from the previous quarter
OMIC's ROS is up by 10% year-on-year and by 4.2% since the previous quarter
The return on invested capital has declined by 8% since the previous quarter
Dividends
What is OMIC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for OMIC.
Financial health
How did Singular Genomics Systems financials performed over time
Singular Genomics Systems's total assets is 195% higher than its total liabilities
OMIC's quick ratio is down by 48% year-on-year and by 18% since the previous quarter
The company's current ratio fell by 46% YoY and by 16% QoQ
Singular Genomics Systems's debt is 59% lower than its equity
Singular Genomics Systems's equity has decreased by 38% YoY and by 10% QoQ
Singular Genomics Systems's debt has decreased by 34% YoY and by 30% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.